171
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Colon targeted dosage form of Capecitabine using folic acid anchored modified carbon nanotube: in vitro cytotoxicity, apoptosis and in vivo roentgenographic study

ORCID Icon, , , , ORCID Icon &
Pages 1401-1412 | Received 30 Apr 2021, Accepted 09 Oct 2021, Published online: 26 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dheeraj S. Randive, Somnath D. Bhinge, Mangesh A. Bhutkar, Namdeo R. Jadhav & Mrunal K. Shirsat. (2023) Single walled Carbon nanotube: Chitosan conjugate for sustained ophthalmic delivery of Ciprofloxacin from ointment; its evaluation and in vivo eye irritation study. Separation Science and Technology 58:4, pages 775-788.
Read now

Articles from other publishers (2)

Elmira Zolali, Sina Rashedi, Elaheh Dalir Abdolahinia, Nasim Rashedi, Saeideh Allahyari & Nastaran Hashemzadeh. 2023. Principles of Biomaterials Encapsulation : Volume Two. Principles of Biomaterials Encapsulation : Volume Two 589 660 .
Mangesh A. Bhutkar, Dheeraj S. Randive, Somnath D. Bhinge, Ganesh H. Wadkar, Sachin S. Todkar & Kiran P. Shejawal. (2022) Development of gold, silver, and iron nanoparticles using isolated berberine: its characterization and antimicrobial and cytotoxic activities against COLO320DM and Hela cells. Gold Bulletin 55:1, pages 93-103.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.